Trials / Sponsors / FutureChem
FutureChem
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | [18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer High Risk Prostate Carcinoma | Phase 3 | 2023-05-08 |
| Active Not Recruiting | [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2 Metastatic Castration-resistant Prostate Cancer, mCRPC | Phase 2 | 2022-10-30 |
| Recruiting | [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application Metastatic Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | 2022-09-01 |
| Active Not Recruiting | Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis High Risk Prostate Carcinoma | Phase 3 | 2021-04-28 |
| Completed | [177Lu]Ludotadipep Treatment in Patients With Metastatic Castration-resistant Prostate Cancer. Metastatic Castration-resistant Prostate Cancer | Phase 1 | 2020-10-14 |